Kimberly-Clark

Kimberly-Clark

Price: 101.58

Company and Business Model

Kimberly-Clark Corporation is a global leader in consumer staples, specializing in the production of personal care products, paper goods, and health and hygiene items. Its core brands include Huggies, Kleenex, Scott, and Kotex. The company operates primarily in the consumer products segment, generating revenue through the sale of disposable diapers, tissues, and feminine hygiene products. Major revenue sources include retail and institutional sales across various markets worldwide.

Investment Profile

The investment profile of Kimberly-Clark is more aligned with dividends, appealing to investors seeking income through regular payouts. The company has a stable dividend yield, indicating a focus on returning value to shareholders. Its moderate growth potential and relatively low volatility suggest it may suit investors with a balanced approach, looking for steady returns rather than aggressive growth.

Official website

Fundamental metrics (experimental)

EPS (TTM) — earnings per share for the last 12 months, $
6.37 OK
Revenue QoQ — quarter-over-quarter revenue growth
2.0%
EPS surprise
2.1% in line
20d volatility
1.7% stable
Dividend yield
5.2% high last ex-date: 2026-06-05
FMP / FinFeed data updated: 2026-06-09
Reco: Buy Potential: 70 Risk: 40 Updated: 2026-06-11 05:21
How recommendation works
Why AI thinks so:
Stable dividend, moderate growth, but mixed momentum signals.

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
AI recommendation changes
Date Before After Reason
2026-06-11 05:21 Sell Buy Stable dividend, moderate growth, but mixed momentum signals.
2026-05-30 02:43 Buy Sell Weak momentum and high risk; dividend yield attractive.
2026-05-22 02:50 Hold Buy Stable dividend but mixed momentum and recent performance.
Analyst forecasts
Date Analyst Action Target Price Then
2026-04-29 12:11 UBS Target Raised 105 → 106 97.4
2026-04-14 12:54 Barclays Target Lowered 105 → 99 97.095
2026-04-08 10:45 Wells Fargo Target Lowered 110 → 100 97

Other stocks in Потребсектор

Kimberly-Clark

Кенвью (Kenvue) и Кимберли-Кларк (Kimberly-Clark) ожидают роста выручки на фоне партнерства с PGA TOUR и спроса на товары для аллергиков

Весной в США начинается сезон аллергий, который длится с февраля по начало июня, с пиковыми уровнями пыльцы деревьев в марте и до середины мая.
Enterprise Products Partners Vici Properties Unilever Kimberly-Clark

Инвестор Дженни Харрингтон рекомендует дивидендные акции для защиты от рисков, связанных с ИИ

Инвесторы, стремящиеся защитить себя от рисков, связанных с искусственным интеллектом, могут обратить внимание на дивидендные акции, как утверждает инвестор Дженни Харрингтон.
Kimberly-Clark

Генеральный директор Kimberly-Clark обсудил приобретение Kenvue и назвал бренд Tylenol «устойчивым»

11/04/2025, 12:35 AM business Kimberly-Clark
Генеральный директор Kimberly-Clark Майк Хсу сообщил CNBC, что запланированное приобретение компании Kenvue, производителя Tylenol, создаст ценность для акционеров, несмотря на критику со стороны администрации Трампа.